Transcription Elongation Factor, Mitochondrial (TEFM) (N-Term) Peptide
-
- Target See all TEFM products
- TEFM (Transcription Elongation Factor, Mitochondrial (TEFM))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- NLESLMNVPL FKYKSTVQVC NSILCPKTGR EKRKSPENRF LRKLLKPDIE
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-TEFM Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- TEFM (Transcription Elongation Factor, Mitochondrial (TEFM))
- Synonyms
- C17orf42 Peptide, TEFM Peptide, zgc:153083 Peptide, RGD1306595 Peptide, transcription elongation factor, mitochondrial Peptide, TEFM Peptide, tefm Peptide, Tefm Peptide
- Background
-
TEFM is a transcription elongation factor which increases mitochondrial RNA polymerase processivity. It regulates transcription of the mitochondrial genome, including genes important for the oxidative phosphorylation machinery.
Alias Symbols: C17orf42
Protein Size: 226 - Molecular Weight
- 25 kDa
- Gene ID
- 79736
- NCBI Accession
- NM_024683, NP_078959
-